NUDT6 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is an inhibitor of various growth factors and their receptors. NUDT6 is an anti-sense RNA that may regulate FGF-2, hence Suramin inhibiting FGF receptors, can lead to the functional inhibition of NUDT6's associated pathways. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
PD173074 is a selective FGFR inhibitor. By inhibiting FGFR, which is associated with the pathways NUDT6 may regulate, PD173074 can lead to the functional inhibition of NUDT6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can inhibit the PI3K/AKT pathway, downstream of FGF-2, potentially leading to the inhibition of NUDT6's function in this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are involved in the MAPK/ERK pathway, downstream of FGF-2. As NUDT6 may be involved in this pathway, its inhibition can lead to NUDT6 functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAPK pathway. Through inhibition of JNK, this chemical can lead to functional inhibition of NUDT6 in the MAPK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which is part of the MAPK pathway. Inhibition of p38 MAPK can consequently inhibit NUDT6's function within this signaling pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, like LY294002, and can inhibit the PI3K/AKT pathway, potentially leading to functional inhibition of NUDT6's role in this pathway. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Dorsomorphin is an inhibitor of BMP signaling and can inhibit ALK2, ALK3, and ALK6. As BMP signaling is part of the pathways NUDT6 may regulate, its inhibition could lead to the functional inhibition of NUDT6. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation downstream of FGF-2. Inhibition of mTOR can lead to functional inhibition of NUDT6 due to its potential regulation by FGF-2 signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, and by inhibiting ROCK, it can influence actin cytoskeleton organization. As the actin cytoskeleton can be influenced by FGF-2, this could lead to functional inhibition of NUDT6. | ||||||